Dafna Capital Management LLC 13F holdings, Q1 2026
Holdings as of March 31, 2026 · filings on SEC EDGAR · latest filing →
Dafna Capital Management LLC disclosed 83 US equity positions worth $439.6m in its Q1 2026 13F filing. The largest position was RVMD at 12.8% of the reported book, followed by XBI and STXS.
What did Dafna Capital Management LLC own in Q1 2026? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | RVMD REVOLUTION MEDICINES INC | Healthcare | 12.8% | $56.5m | 580,678 | – | |
| 2 | XBI SPDR S&P BIOTECH ETF | 9.3% | $40.7m | 318,505 | – | ||
| 3 | STXS STEREOTAXIS INC | 5.7% | $25.2m | 13,680,554 | – | ||
| 4 | DAWNGBX DAY ONE BIOPHARMACEUTICALS I | 4.8% | $21.0m | 978,463 | – | ||
| 5 | ATRC ATRICURE INC | Healthcare | 3.9% | $17.0m | 597,431 | – | |
| 6 | IDYA IDEAYA BIOSCIENCES INC | Healthcare | 3.6% | $15.9m | 476,740 | – | |
| 7 | XENE XENON PHARMACEUTICALS INC | Healthcare | 3.3% | $14.6m | 250,772 | – | |
| 8 | CYTK CYTOKINETICS INC | Healthcare | 3.3% | $14.3m | 217,497 | – | |
| 9 | CMPS COMPASS PATHWAYS PLC | Healthcare | 3.0% | $13.4m | 2,418,882 | – | |
| 10 | NKTR NEKTAR THERAPEUTICS | Healthcare | 2.7% | $11.9m | 165,178 | – | |
| 11 | IBB ISHARES NASDAQ BIOTECH INDX | 2.4% | $10.5m | 62,095 | – | ||
| 12 | RCUS ARCUS BIOSCIENCES INC | Healthcare | 2.2% | $9.6m | 443,829 | – | |
| 13 | NBIX NEUROCRINE BIOSCIENCES INC | Healthcare | 2.1% | $9.3m | 70,615 | – | |
| 14 | LRMR LARIMAR THERAPEUTICS INC | Healthcare | 2.1% | $9.1m | 2,029,164 | – | |
| 15 | BCAX BICARA THERAPEUTICS INC | Healthcare | 1.9% | $8.4m | 421,733 | – | |
| 16 | AXGN AXOGEN INC | Healthcare | 1.9% | $8.3m | 249,960 | – | |
| 17 | BHVN BIOHAVEN LTD | Healthcare | 1.6% | $7.2m | 845,735 | – | |
| 18 | TNDM TANDEM DIABETES CARE INC | Healthcare | 1.5% | $6.8m | 355,208 | – | |
| 19 | DNLI DENALI THERAPEUTICS INC | Healthcare | 1.4% | $6.1m | 318,500 | – | |
| 20 | ASND ASCENDIS PHARMA A/S | 1.3% | $5.9m | 4,000,000 | – | ||
| 21 | IPSC CENTURY THERAPEUTICS INC | Healthcare | 1.3% | $5.5m | 2,434,353 | – | |
| 22 | DXCM DEXCOM INC | Healthcare | 1.2% | $5.4m | 86,279 | – | |
| 23 | 4XC1 KALVISTA PHARMACEUTICALS INC | 1.2% | $5.4m | 267,402 | – | ||
| 24 | ASND ASCENDIS PHARMA A/S | Healthcare | 1.2% | $5.3m | 23,177 | – | |
| 25 | MBX MBX BIOSCIENCES INC | Healthcare | 1.2% | $5.2m | 175,465 | – | |
| 26 | INGN INOGEN INC | Healthcare | 1.2% | $5.2m | 845,179 | – | |
| 27 | SNDX SYNDAX PHARMACEUTICALS INC | Healthcare | 1.2% | $5.1m | 217,355 | – | |
| 28 | ALKS ALKERMES PLC | Healthcare | 1.1% | $4.9m | 139,482 | – | |
| 29 | STOK STOKE THERAPEUTICS INC | Healthcare | 1.0% | $4.3m | 130,875 | – | |
| 30 | BCRX BIOCRYST PHARMACEUTICALS INC | Healthcare | 0.9% | $4.1m | 430,248 | – | |
| 31 | LKFT GALAPAGOS NV | Healthcare | 0.9% | $3.9m | 130,175 | – | |
| 32 | IMVT IMMUNOVANT INC | Healthcare | 0.9% | $3.7m | 150,524 | – | |
| 33 | EWTX EDGEWISE THERAPEUTICS INC | Healthcare | 0.8% | $3.5m | 112,236 | – | |
| 34 | MPLT MAPLIGHT THERAPEUTICS INC | 0.8% | $3.5m | 171,006 | – | ||
| 35 | ALLO ALLOGENE THERAPEUTICS INC | Healthcare | 0.8% | $3.3m | 1,370,118 | – | |
| 36 | PRCT PROCEPT BIOROBOTICS CORP | Healthcare | 0.7% | $3.0m | 120,000 | – | |
| 37 | ALGN ALIGN TECHNOLOGY INC | Healthcare | 0.6% | $2.6m | 15,000 | – | |
| 38 | PROQR THERAPEUTICS N V | 0.6% | $2.5m | 1,567,561 | – | ||
| 39 | HELP CYBIN INC | 0.5% | $2.4m | 498,361 | – | ||
| 40 | RAPP RAPPORT THERAPEUTICS INC | 0.5% | $2.3m | 75,000 | – | ||
| 41 | PODD INSULET CORP | Healthcare | 0.5% | $2.3m | 10,870 | – | |
| 42 | GPCR STRUCTURE THERAPEUTICS INC | Healthcare | 0.5% | $2.2m | 46,500 | – | |
| 43 | IMTX IMMATICS NV | Healthcare | 0.5% | $2.2m | 225,860 | – | |
| 44 | CLDX CELLDEX THERAPEUTICS INC | Healthcare | 0.5% | $2.2m | 68,518 | – | |
| 45 | LXEO LEXEO THERAPEUTICS INC | Healthcare | 0.5% | $2.2m | 377,059 | – | |
| 46 | ALEC ALECTOR INC | Healthcare | 0.4% | $2.0m | 908,351 | – | |
| 47 | VKTX VIKING THERAPEUTICS INC | Healthcare | 0.4% | $1.9m | 59,516 | – | |
| 48 | KURA KURA ONCOLOGY INC | Healthcare | 0.4% | $1.9m | 235,868 | – | |
| 49 | PROF PROFOUND MEDICAL CORP | 0.4% | $1.7m | 263,005 | – | ||
| 50 | FULC FULCRUM THERAPEUTICS INC | Healthcare | 0.4% | $1.6m | 205,000 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.